Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Behavior change in a lifestyle intervention for type 2 diabetes prevention in Dutch primary care: opportunities for intervention content.

Vermunt PW, Milder IE, Wielaard F, Baan CA, Schelfhout JD, Westert GP, van Oers HA.

BMC Fam Pract. 2013 Jun 7;14:78. doi: 10.1186/1471-2296-14-78.

2.

Implementation of a lifestyle intervention for type 2 diabetes prevention in Dutch primary care: opportunities for intervention delivery.

Vermunt PW, Milder IE, Wielaard F, Baan CA, Schelfhout JD, Westert GP, van Oers HA.

BMC Fam Pract. 2012 Aug 8;13:79.

3.

A lifestyle intervention to reduce Type 2 diabetes risk in Dutch primary care: 2.5-year results of a randomized controlled trial.

Vermunt PW, Milder IE, Wielaard F, de Vries JH, Baan CA, van Oers JA, Westert GP.

Diabet Med. 2012 Aug;29(8):e223-31. doi: 10.1111/j.1464-5491.2012.03648.x.

PMID:
22416789
4.

Lifestyle counseling for type 2 diabetes risk reduction in Dutch primary care: results of the APHRODITE study after 0.5 and 1.5 years.

Vermunt PW, Milder IE, Wielaard F, de Vries JH, van Oers HA, Westert GP.

Diabetes Care. 2011 Sep;34(9):1919-25. doi: 10.2337/dc10-2293. Epub 2011 Jul 20.

5.

An active strategy to identify individuals eligible for type 2 diabetes prevention by lifestyle intervention in Dutch primary care: the APHRODITE study.

Vermunt PW, Milder IE, Wielaard F, van Oers JA, Westert GP.

Fam Pract. 2010 Jun;27(3):312-9. doi: 10.1093/fampra/cmp100. Epub 2010 Jan 20.

PMID:
20089573
6.

Development of an antibody-capture IgM-enzyme-linked immunosorbent assay for diagnosis of acute Epstein-Barr virus infections.

Wielaard F, Scherders J, Dagelinckx C, Middeldorp JM, Sabbe LJ, Van Belzen C.

J Virol Methods. 1988 Sep;21(1-4):105-15.

PMID:
2846605
7.

Diagnosis of fetal rubella infection by nucleic acid hybridization.

Ho-Terry L, Terry GM, Londesborough P, Rees KR, Wielaard F, Denissen A.

J Med Virol. 1988 Feb;24(2):175-82.

PMID:
3351485
8.

Use of an IgM-ELISA for diagnosis of acute toxoplasmosis.

Wielaard F.

Wiad Parazytol. 1988;34(3):255-8. No abstract available.

PMID:
3232381
9.

A sol-particle immunoassay for determination of anti-rubella antibodies; development and clinical validation.

Wielaard F, Denissen A, van der Veen L, Rutjes I.

J Virol Methods. 1987 Aug;17(1-2):149-58.

PMID:
3667854
10.

A one-step enzyme-linked immunosorbent assay to detect anti-CMV antibodies; development and clinical validation.

Wielaard F, Scherders J, Dagelinckx C, Gausset P.

J Virol Methods. 1987 Aug;17(1-2):141-8.

PMID:
2822750
11.

Development of CMV antibody tests and their clinical evaluation.

Wielaard F, Scherders J, Dagelinckx C, Hooijmans A, Smit-Siebinga CT, Welle F.

Vox Sang. 1986;51 Suppl 1:31-4.

PMID:
3017004
12.

Clinical validation of an antibody-capture anti-rubella IgM-ELISA.

Wielaard F, Denissen A, Van Elleswijk-vd Berg J, Van Gemert G.

J Virol Methods. 1985 Apr;10(4):349-54.

PMID:
3998043
13.

Development and preliminary evaluation of two ELISAs for detection of anti-CMV Ig and IgM antibodies.

Wielaard F, Scherders J, Hooijmans A, Dagelinckx C.

J Virol Methods. 1985 Apr;10(4):363-9. No abstract available.

PMID:
2987284
14.

Diagnosis of acute toxoplasmosis by an enzyme immunoassay for specific immunoglobulin m antibodies.

Wielaard F, van Gruijthuijsen H, Duermeyer W, Joss AW, Skinner L, Williams H, van Elven EH.

J Clin Microbiol. 1983 Jun;17(6):981-7.

15.

Enzyme-linked immunosorbent assay for detection of immunoglobulin M antibodies against Toxoplasma gondii.

Duermeyer W, Wielaard F, van Gruijthuijsen H, Swinkels J.

J Clin Microbiol. 1980 Dec;12(6):805-6.

16.

An outbreak of hepatitis A in an institution for the mentally retarded.

Helmsing PJ, Duermeyer W, van Hattem GC, Wielaard F.

J Med Virol. 1980;5(2):143-50.

PMID:
6246198
17.

[Hepatitis A in an institute for mentally retarded].

Duermeyer W, van Hattem GC, Helmsing PJ, van der Veen-du Prie J, Wielaard F.

Ned Tijdschr Geneeskd. 1979 Aug 4;123(31):1330-4. Dutch. No abstract available.

PMID:
394005
18.

A new principle for the detection of specific IgM antibodies applied in an ELISA for hepatitis A.

Duermeyer W, Wielaard F, van der Veen J.

J Med Virol. 1979;4(1):25-32.

PMID:
231096

Supplemental Content

Loading ...
Support Center